title: Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop.
authors.affiliation: University of Colorado School of Medicine, Denver, CO, USA. tmughal911@hotmail.com
authors.forename: Tariq I
authors.initials: TI
authors.lastname: Mughal
authors.forename: Jerald P
authors.initials: JP
authors.lastname: Radich
authors.forename: Richard A
authors.initials: RA
authors.lastname: Van Etten
authors.forename: Alfonso
authors.initials: A
authors.lastname: Quintás-Cardama
authors.forename: Tomasz
authors.initials: T
authors.lastname: Skorski
authors.forename: Farhad
authors.initials: F
authors.lastname: Ravandi
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: DeAngelo
authors.forename: Carlo
authors.initials: C
authors.lastname: Gambacorti-Passerini
authors.forename: Giovanni
authors.initials: G
authors.lastname: Martinelli
authors.forename: Ayalew
authors.initials: A
authors.lastname: Tefferi
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016903:Drug Monitoring; D019008:Drug Resistance, Neoplasm; D042822:Genomic Instability; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D054438:Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents